| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_679bc5b56f445f45e17ae66add2c6967 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2020-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_598b6c8715f7b8cc9c7bfc389399f799
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e139eb33f42ac35a33fbcb962273559b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0520a9bac29180e71fc8d7e8357f906e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a533f22a98a1181d49e958bdc1ddce9 |
| publicationDate |
2020-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020215842-A1 |
| titleOfInvention |
Lrpprc negative regulator and use thereof |
| abstract |
An LRPPRC negative regulator and use thereof. High expression of LRPPRC in tumor cells is used as a treatment target, and gossypol acetate is used as a targeted therapeutic drug. The purpose of inhibiting the growth of tumor cells is achieved by means of the specific binding of the two. |
| priorityDate |
2019-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |